General Information of the Protein
| Protein ID |
PT04413
|
||||
|---|---|---|---|---|---|
| Protein Name |
Vitamin K epoxide reductase complex subunit 1
|
||||
| Secondarily Protein Name |
Vitamin K1 2,3-epoxide reductase subunit 1
|
||||
| Gene Name |
VKORC1
|
||||
| Secondarily Gene Name |
VKOR
MSTP134
MSTP576
UNQ308/PRO351
|
||||
| Sequence |
MGSTWGSPGWVRLALCLTGLVLSLYALHVKAARARDRDYRALCDVGTAISCSRVFSSRWGRGFGLVEHVLGQDSILNQSNSIFGCIFYTLQLLLGCLRTRWASVLMLLSSLVSLAGSVYLAWILFFVLYDFCIVCITTYAINVSLMWLSFRKVQEPQGKAKRH
Show/Hide
|
||||
| Organism |
Homo sapiens, Human
|
||||
| Protein Classification |
Enzyme
>
Oxidoreductase
|
||||
| Function |
Involved in vitamin K metabolism. Catalytic subunit of the vitamin K epoxide reductase (VKOR) complex which reduces inactive vitamin K 2,3-epoxide to active vitamin K. Vitamin K is required for the gamma-carboxylation of various proteins, including clotting factors, and is required for normal blood coagulation, but also for normal bone development.
Show/Hide
|
||||
| Uniprot ID |
Show/Hide
|
||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Subcellular Location |
Endoplasmic reticulum membrane
|
||||
Map of Molecular Bioactivity Related to the Protein
|
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000006 , HEK293
Clinical Information about the Protein
Target 1 ( Vitamin K epoxide reductase complex 1 (VKORC1) )
| Target Type | Successful Target | ||||
|---|---|---|---|---|---|
| Disease | 3 Target-related Diseases | 3 | |||
| 1 | Thrombosis [ICD-11: DB61-GB90] | ||||
| 2 | Coagulation defect [ICD-11: 3B10.0] | ||||
| 3 | Atrial fibrillation [ICD-11: BC81.3] | ||||
| Approved Drug(s) | 5 Approved Drugs | 5 | |||
| 1 | Acenocoumarol | Approved | |||
| 2 | Dicumarol | Approved | |||
| 3 | Phenindione | Approved | |||
| 4 | Phenprocoumon | Approved | |||
| 5 | Warfarin | Approved | |||